Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis.

Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis.
复制标题

DOI:
10.3390/molecules26010157
复制
发表时间:
2020-12-31
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
通讯作者:
King MR
King MR
中科院分区:
其他
文献类型:
--
作者:
Zhang Z;Patel SB;King MR

文献摘要

参考文献

被引文献

相似文献

肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor related apoptosis inducing ligand,TRAIL)能诱导肿瘤细胞特异性凋亡,作为一种有前途的肿瘤治疗药物,已引起人们的极大兴趣。然而,TRAIL的发展受到阻碍,部分原因是大多数人类癌细胞对TRAIL具有抗性。一些小分子,包括天然化合物,如piperlongumine(PL)已被报道,敏感癌细胞的TRAIL。我们制备了一种新型纳米材料--脂质体中的胶束(MIL),用于增溶和递送PL。负载PL的MIL用于使癌细胞对TRAIL敏感。如通过cryo-TEM观察到的,胶束成功地装载在脂质体的水性核心内。MIL使PL的水溶性增加约20倍。实现了在生理相关缓冲液中从MIL中持续释放PL超过7天,表明脂质体防止了药物从MIL中的胶束中过早释放。还证明了PL MIL与脂质体TRAIL结合在癌细胞中的有效协同凋亡作用。MIL为疏水性抗癌剂提供了新的制剂和递送载体,其可以单独使用或与TRAIL组合使用以促进癌细胞死亡。
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces cancer cell-specific apoptosis and has garnered intense interest as a promising agent for cancer treatment. However, the development of TRAIL has been hampered in part because most human cancer cells are resistant to TRAIL. A few small molecules including natural compounds such as piperlongumine (PL) have been reported to sensitize cancer cells to TRAIL. We prepared a novel type of nanomaterial, micelle-in-liposomes (MILs) for solubilization and delivery of PL. PL-loaded MILs were used to sensitize cancer cells to TRAIL. As visualized by cryo-TEM, micelles were successfully loaded inside the aqueous core of liposomes. The MILs increased the water solubility of PL by ~20 fold. A sustained PL release from MILs in physiologically relevant buffer over 7 days was achieved, indicating that the liposomes prevented premature drug release from the micelles in the MILs. Also demonstrated is a potent synergistic apoptotic effect in cancer cells by PL MILs in conjunction with liposomal TRAIL. MILs provide a new formulation and delivery vehicle for hydrophobic anticancer agents, which can be used alone or in combination with TRAIL to promote cancer cell death.
DOI: 10.1039/d0na00271b
发表时间: 2020-09-16
期刊: Nanoscale advances
影响因子: 4.7
作者:
通讯作者: --
DOI: 10.1007/s11095-010-0233-4
发表时间: 2010-12
影响因子: 3.7
作者:
Oerlemans C;Bult W;Bos M;Storm G;Nijsen JF;Hennink WE
通讯作者: Hennink WE
DOI: 10.1021/ma200675w
发表时间: 2011-08-09
期刊: Macromolecules
影响因子: 5.5
作者:
Lu J;Owen SC;Shoichet MS
通讯作者: Shoichet MS
DOI: 10.1081/bio-120028669
发表时间: 2004-01-01
期刊: ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY
影响因子: --
作者:
Chaize, B;Colletier, JP;Fournier, D
通讯作者: Fournier, D
DOI: 10.1186/s12885-020-07376-1
发表时间: 2020-09-11
期刊: BMC CANCER
影响因子: 3.8
作者:
Ortiz-Otero, Nerymar;Marshall, Jocelyn R.;King, Michael R.
通讯作者: King, Michael R.